BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15951191)

  • 41. NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease.
    Zhang H; Petit GH; Gaughwin PM; Hansen C; Ranganathan S; Zuo X; Smith R; Roybon L; Brundin P; Mobley WC; Li JY
    J Huntingtons Dis; 2013; 2(1):69-82. PubMed ID: 25063430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FoxG1 haploinsufficiency results in impaired neurogenesis in the postnatal hippocampus and contextual memory deficits.
    Shen L; Nam HS; Song P; Moore H; Anderson SA
    Hippocampus; 2006; 16(10):875-90. PubMed ID: 16941454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Orexin loss in Huntington's disease.
    Petersén A; Gil J; Maat-Schieman ML; Björkqvist M; Tanila H; Araújo IM; Smith R; Popovic N; Wierup N; Norlén P; Li JY; Roos RA; Sundler F; Mulder H; Brundin P
    Hum Mol Genet; 2005 Jan; 14(1):39-47. PubMed ID: 15525658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased generation of granule cells in adult Bcl-2-overexpressing mice: a role for cell death during continued hippocampal neurogenesis.
    Kuhn HG; Biebl M; Wilhelm D; Li M; Friedlander RM; Winkler J
    Eur J Neurosci; 2005 Oct; 22(8):1907-15. PubMed ID: 16262630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene.
    Hansson O; Guatteo E; Mercuri NB; Bernardi G; Li XJ; Castilho RF; Brundin P
    Eur J Neurosci; 2001 Nov; 14(9):1492-504. PubMed ID: 11722611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hairy and Enhancer of Split 6 (Hes6) Deficiency in Mouse Impairs Neuroblast Differentiation in Dentate Gyrus Without Affecting Cell Proliferation and Integration into Mature Neurons.
    Nam SM; Kim YN; Kim JW; Kyeong DS; Lee SH; Son Y; Shin JH; Kim J; Yi SS; Yoon YS; Seong JK
    Cell Mol Neurobiol; 2016 Jan; 36(1):57-67. PubMed ID: 26105991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regeneration of granule neurons after lesioning of hippocampal dentate gyrus: evaluation using adult mice treated with trimethyltin chloride as a model.
    Ogita K; Nishiyama N; Sugiyama C; Higuchi K; Yoneyama M; Yoneda Y
    J Neurosci Res; 2005 Dec; 82(5):609-21. PubMed ID: 16273549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington's Disease.
    Dallérac GM; Cummings DM; Hirst MC; Milnerwood AJ; Murphy KP
    Neuromolecular Med; 2016 Mar; 18(1):146-53. PubMed ID: 26782175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice.
    Rodriguez-Lebron E; Denovan-Wright EM; Nash K; Lewin AS; Mandel RJ
    Mol Ther; 2005 Oct; 12(4):618-33. PubMed ID: 16019264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time course of morphine's effects on adult hippocampal subgranular zone reveals preferential inhibition of cells in S phase of the cell cycle and a subpopulation of immature neurons.
    Arguello AA; Harburg GC; Schonborn JR; Mandyam CD; Yamaguchi M; Eisch AJ
    Neuroscience; 2008 Nov; 157(1):70-9. PubMed ID: 18832014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model.
    Im W; Ban JJ; Chung JY; Lee ST; Chu K; Kim M
    Sci Rep; 2015 Nov; 5():16887. PubMed ID: 26586297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostaglandin E2 EP2 activation reduces memory decline in R6/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity.
    Anglada-Huguet M; Vidal-Sancho L; Giralt A; García-Díaz Barriga G; Xifró X; Alberch J
    Neurobiol Dis; 2016 Nov; 95():22-34. PubMed ID: 26369879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease.
    Johnson MA; Rajan V; Miller CE; Wightman RM
    J Neurochem; 2006 May; 97(3):737-46. PubMed ID: 16573654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain region- and age-dependent dysregulation of p62 and NBR1 in a mouse model of Huntington's disease.
    Rué L; López-Soop G; Gelpi E; Martínez-Vicente M; Alberch J; Pérez-Navarro E
    Neurobiol Dis; 2013 Apr; 52():219-28. PubMed ID: 23295856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A decrease of cell proliferation by hypothermia in the hippocampus of the neonatal rat.
    Kanagawa T; Fukuda H; Tsubouchi H; Komoto Y; Hayashi S; Fukui O; Shimoya K; Murata Y
    Brain Res; 2006 Sep; 1111(1):36-40. PubMed ID: 16904084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Temporal profile of neurogenesis in the subventricular zone, dentate gyrus and cerebral cortex following transient focal cerebral ischemia.
    Kuge A; Takemura S; Kokubo Y; Sato S; Goto K; Kayama T
    Neurol Res; 2009 Nov; 31(9):969-76. PubMed ID: 19138475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age-dependent alterations of the hippocampal cell composition and proliferative potential in the hAβPPSwInd-J20 mouse.
    Fu Y; Rusznák Z; Kwok JB; Kim WS; Paxinos G
    J Alzheimers Dis; 2014; 41(4):1177-92. PubMed ID: 24787919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease.
    García-Martínez JM; Pérez-Navarro E; Xifró X; Canals JM; Díaz-Hernández M; Trioulier Y; Brouillet E; Lucas JJ; Alberch J
    J Neurosci Res; 2007 Sep; 85(12):2756-69. PubMed ID: 17387706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6/2 mouse model of Huntington's disease.
    Kung VW; Hassam R; Morton AJ; Jones S
    Neuroscience; 2007 Jun; 146(4):1571-80. PubMed ID: 17478055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease.
    Jin K; LaFevre-Bernt M; Sun Y; Chen S; Gafni J; Crippen D; Logvinova A; Ross CA; Greenberg DA; Ellerby LM
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18189-94. PubMed ID: 16326808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.